Home » US Court Invalidates Sanofi’s Taxotere Patents
US Court Invalidates Sanofi’s Taxotere Patents
Two Sanofi-Aventis SA patents on the cancer drug Taxotere were invalidated by a U.S. court on Monday, clearing the way for Hospira Inc to launch a generic version by the end of the year.
CNBC
CNBC
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May